Alvotech (ALVO) Stock Soars 8% Following Barclays Upgrade to Overweight
Alvotech (ALVO) stock rallied 8% after Barclays upgraded the company to Overweight with an $8 price target following FDA facility clearance in Iceland.
The post Alvotech (ALVO) Stock Soars 8% Following Barclays Upgrade to Overweight appeared first on Blockonomi.
Source: Source: Blockonomi